NCT06193889 2026-04-06
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Kyverna Therapeutics
Phase 2/3 Recruiting
Clinical Trials
12 trialsNCT07157514 2025-09-10
Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML
Actinium Pharmaceuticals
Phase 2/3 Not yet recruiting
NCT07052422 2025-07-04
VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT
Nanfang Hospital, Southern Medical University
Phase 2/3 Not yet recruiting
NCT03937544 2025-05-29
Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL
National University of Malaysia
Phase 2/3 Recruiting
NCT01949129 2024-01-16
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
St. Anna Kinderkrebsforschung
Phase 2/3 Recruiting
NCT04217278 2023-05-10
COSI
University of Birmingham
Phase 2/3 Unknown
NCT00096460 2023-01-05
BMT CTN 0202
Medical College of Wisconsin
Phase 2/3 Terminated
NCT05578378 2022-10-13
Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL
The First Affiliated Hospital of Soochow University
Phase 2/3 Unknown
NCT02707393 2021-04-15
Allogeneic Stem Cell Transplantation for Children With CML
St. Anna Kinderkrebsforschung
Phase 2/3 Completed
NCT00641095 2018-10-31
MCLPIII
University College, London
Phase 2/3 Completed
NCT00714259 2017-07-24
Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies
University of Alabama at Birmingham
Phase 2/3 Terminated
NCT01423032 2011-08-25
Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)
WiSP Wissenschaftlicher Service Pharma GmbH
Phase 2/3 Completed